Recursion Pharmaceuticals (RXRX) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

RXRX Recursion Pharmaceuticals

Watchlist

7.510
-0.160-2.09%

Close Feb 28 16:00 ET

7.570
+0.060+0.80%

Post 19:59 ET

3.02BMarket Cap-4.44P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Recursion Pharmaceuticals Full Year 2024 Earnings: Misses Expectations
Yahoo FinanceMar 1 08:31 ET
Cathie Wood's Ark Invest Loads Up On Tempus AI, Archer Aviation, But Sells Twist Bioscience: Here Are Key Ark Trades This Friday
BenzingaMar 1 05:06 ET
Cathie Wood's ARK Investment Buys 653K Shares of Recursion Pharmaceuticals Today
TipRanksFeb 28 20:05 ET
Leerink Partners Maintains Market Perform on Recursion Pharmaceuticals, Lowers Price Target to $6
BenzingaFeb 28 16:32 ET · Ratings
Recursion Pharmaceuticals Analyst Ratings
BenzingaFeb 28 16:28 ET · Ratings
Needham Maintains Recursion Pharmaceuticals(RXRX.US) With Buy Rating, Maintains Target Price $11
Moomoo NewsFeb 28 15:31 ET · Ratings

Comments

Phil Dunn

8 hours ago

Weekly Trading Report (4th Week Feb)

A Quick Review of my Trading Activities in this week ( 24 - 28 Feb 2025 ).
Market Overview
- Ongoing uncertainties related to US tariffs and President Trump’s policies exerted downward pressure on the $S&P 500 Index (.SPX.US)$ this week, resulting in a net decline despite a notable recovery on Friday.
- PCE data met expectations, temporarily easing market concerns about high inflation. However, the potential for US tariffs to drive inflation remains a significa...